Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
20 enrolled 20 charts
Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
Phase 2 Completed
21 enrolled 18 charts
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Phase 2 Completed
139 enrolled 14 charts
Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer
Phase 2 Completed
54 enrolled
MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1/2 Completed
12 enrolled
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 2 Completed
14 enrolled
Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Phase 3 Completed
216 enrolled
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
Phase 2 Completed
36 enrolled
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
55 enrolled 11 charts
G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
Phase 2 Completed
5 enrolled 9 charts
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
Phase 3 Completed
671 enrolled 10 charts
Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
72 enrolled 10 charts
Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Phase 1 Completed
19 enrolled
High-dose ICE With Amifostine
Phase 2 Completed
24 enrolled
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 2 Completed
41 enrolled
Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
75 enrolled
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
65 enrolled
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 1/2 Completed
73 enrolled
Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
78 enrolled
Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Phase 2 Completed
38 enrolled
Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
Phase 3 Completed
429 enrolled
Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
79 enrolled
Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Phase 3 Completed
610 enrolled
Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1/2 Completed
56 enrolled
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 3 Completed
4 enrolled
Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer
Phase 3 Completed
400 enrolled
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer
Phase 3 Completed
398 enrolled
S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Phase 2 Completed
46 enrolled 9 charts
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
34 enrolled
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
Phase 1/2 Completed
55 enrolled
Phase I Safety and Tolerability Study of Cediranib (RECENTINâ„¢, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients
Phase 1 Completed
62 enrolled
Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)
Phase 2 Completed
26 enrolled
SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Completed
116 enrolled
S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
Phase 1 Completed
30 enrolled
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 2 Completed
8 enrolled
S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Completed
96 enrolled
Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer
Phase 3 Completed
724 enrolled
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
20 enrolled